Bone Marrow Morphology Associated With Germline RUNX1 Mutations in Patients With Familial Platelet Disorder With Associated Myeloid Malignancy

Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas

(2018) Jean E. Goasguen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

(2017) Rashmi Kanagal-Shamanna et al.   HAEMATOLOGICA

Germline Genetic Predisposition to Hematologic Malignancy

(2017) Elissa Furutani et al.   JOURNAL OF CLINICAL ONCOLOGY

Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases

(2017) Hamilton C Tsang et al.   MODERN PATHOLOGY

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

(2017) Rashmi Kanagal-Shamanna et al.   HAEMATOLOGICA

Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy

(2016) Chi Young Ok et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

(2016) Peter L. Greenberg et al.   Journal of the National Comprehensive Cancer Network

Are micromegakaryocytes specific for refractory cytopenia of childhood (RCC)? A study of 38 pediatric patients with thrombocytopenia unrelated to RCC

(2016) Barina Aqil et al.   LEUKEMIA RESEARCH

Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia

(2016) Jean E. Goasguen et al.   LEUKEMIA RESEARCH

Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders

(2016) Veronique Latger-Cannard et al.   Orphanet Journal of Rare Diseases

Genetic predisposition syndromes: When should they be considered in the work-up of MDS?

(2015) Daria V. Babushok et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia

(2015) J. E. Churpek et al.   BLOOD

RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation

(2015) O. N. Kuvardina et al.   BLOOD

Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia

(2015) Karl Haslam et al.   BRITISH JOURNAL OF HAEMATOLOGY

Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis

(2015) Hiromitsu Iizuka et al.   EXPERIMENTAL HEMATOLOGY

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

(2015) I Antony-Debré et al.   LEUKEMIA

Analyses of Genetic and Clinical Parameters for Screening Patients With Inherited Thrombocytopenia with Small or Normal-Sized Platelets

(2015) Meri Ouchi-Uchiyama et al.   PEDIATRIC BLOOD & CANCER

Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia

(2014) I. Antony-Debre et al.   BLOOD

Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity

(2014) M. Y. Zhang et al.   HAEMATOLOGICA

Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets

(2014) A. C. Glembotsky et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

(2014) M G Della Porta et al.   LEUKEMIA

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients

(2014) M Sakurai et al.   LEUKEMIA

Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes

(2014) Jean E. Goasguen et al.   LEUKEMIA RESEARCH

Recurrent CDC25C mutations drive malignant transformation in FPD/AML

(2014) Akihide Yoshimi et al.   Nature Communications

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects

(2013) J. Stockley et al.   BLOOD

Bone marrow evaluation for pediatric patients

(2013) M. Proytcheva   International Journal of Laboratory Hematology

Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression

(2012) D. Bluteau et al.   BLOOD

Direct Recruitment of Polycomb Repressive Complex 1 to Chromatin by Core Binding Transcription Factors

(2012) Ming Yu et al.   MOLECULAR CELL

Morphometric evaluation of megakaryocytes in bone marrow aspirates of immune-mediated thrombocytopenic purpura

(2012) Lopamudra Deka et al.   PLATELETS

Dysmegakaryopoiesis, a Clue for an Early Diagnosis of Familial Platelet Disorder With Propensity to Acute Myeloid Leukemia in Case of Unexplained Inherited Thrombocytopenia Associated With Normal-sized Platelets

(2011) Véronique Latger-Cannard et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

(2009) C. Preudhomme et al.   BLOOD